ArticleFrontiers in public health2026
Advancing epidemic intelligence: evaluating Senegal's mpox surveillance system and readiness for AI-driven predictive modelling.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Mpox has re-emerged as a public health issue in West Africa, underscoring the need for robust surveillance systems that can detect outbreaks and facilitate effective responses. This study evaluates Senegal's mpox surveillance system, focusing on performance, data quality, governance, and potential for Artificial Intelligence-powered, predictive epidemic intelligence. It reviews trends and system operations while exploring AI and modeling to improve early warnings. Methodology: A descriptive, exploratory approach combined quantitative and qualitative data from various sources. A retrospective review of mpox cases from January 2024 to October 2025 utilized DHIS2 Tracker to analyze geographical, temporal, and demographic patterns, as well as reporting delays and biases. Data-quality checks and stakeholder interviews provided insights into system performance, intersectoral coordination, and preparedness for advanced analytics. Results: By late October 2025, Senegal had reported seven mpox cases, all in Dakar, primarily affecting young, mobile populations, with a higher incidence among children and working-age adults. Transmission followed population movement along the Dakar-Thiès-Diourbel corridor, showing how urban density and mobility influence spread. The surveillance system improved reporting, geolocation, and follow-up, supported by One Health coordination and digital health infrastructure. Challenges include underreporting in rural areas, uneven coverage, limited real-time analytics, and gaps in data interoperability and responsible AI regulation. The AI4MPOX-SN initiative offers an opportunity to enhance epidemic intelligence by integrating human-animal-environment data, using AI for anomaly detection and predictive modeling to inform interventions. Conclusion: To develop predictive epidemic intelligence in Senegal, it's vital to involve local stakeholders, promote transparency, build workforce capacity, and establish safeguards for the ethical use of data. Combining technology, participatory governance, and institutional strengthening will enable Senegal to transition from reactive detection to proactive surveillance, positioning it as a regional leader in health security in West Africa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.